Object. Utilization of covered stent grafts in treating neurovascular disorders has been reported, but their ef ficacy and safety in vertebral artery (VA) dissecting aneurysms needs further investigation.
T he annual incidence of intracranial VA dissecting aneurysms is estimated to be 1-1.5 per 100,000 people, and are increasingly recognized as a cause of stroke and devastating SAH. 10, 37 Although the treatment of cerebral aneurysms has exhibited noticeable improve ments in recent years with the advent of microsurgical and endovascular techniques, 38 VA dissecting aneurysms are still believed to be difficult to treat due to their deep position, morphological features, and proximity to some important branches arteries such as the PICA and ASA. 4 A wide variety of treatment regimens have been advo cated for intracranial VA dissecting aneurysms, including antithrombotic treatment, 23, 30 surgical trapping or wrap ping, 42, 43 endovascular trapping, and proximal occlusion, using balloons and coils, with or without stents. 14, 33, 40 Re cently, another exciting development in stent technology has evolved-the use of covered stent grafts to obliterate the dissecting aneurysm from the VA without coil embo lization. This innovative stent technology has the theoreti cal advantage of obliterating blood flow into aneurysms, as well as reconstruction of the parent vessels. Covered stent grafts have been used primarily in aneurysms involving vascular territories that are easier to access than the intra cranial vasculature, such as the abdominal aorta, axillary artery, subclavian arteries, popliteal artery, and iliac and femoral arteries. In the past decade, covered stents have been used in the proximal extracranial carotid artery and VA to treat traumatic aneurysms or fistulas. In the past 6 years covered stent grafts have been successfully applied in treating intracranial vascular diseases, including CCFs and intracranial aneurysms (traumatic, giant, fusiform, and dissecting aneurysms). In this paper we present our expe rience using covered stent grafts to treat intracranial VA dissecting aneurysms in 6 patients, with 6-14 months of angiographic followup.
Methods

Patient Population
This study included 6 consecutive cases of intracrani al VA dissecting aneurysms treated using Jostent covered stent graft (Graftmaster, Abbott Vascular) placement at a single institution (the Neurosurgery Department of West China Hospital) between November 2005 and December 2006. During the same period, 31 intracranial aneurysms were treated using endovascular techniques, and 217 were treated using microsurgical clip placement. The 6 cases were composed of 5 men and 1 woman, with a mean age of 41 years (range 28-57 years). All patients were symp tomatic. One patient was admitted for chronic headache, and the other 5 for SAH. In all cases, CT scanning was performed to detect if SAH and hydrocephalus were pres ent, and DS angiography was performed to determine the location of the aneurysm. Four aneurysms were located in the VAs proximal to the PICAs, and 2 were located in the VAs distal to the PICAs (Table 1) .
This study included patients with VA dissecting an eurysms in whom the use of conventional techniques such as microsurgical clip placement and endovascular coil embolization (with or without stent placement) would not satisfactorily treat the aneurysms. Patients were selected in accordance with the following criteria: 1) the involved VAs should not be tortuous with deep curves; 2) the cov ered stents could easily traverse the dissection; and 3) the dissection had to be distant from important blood vessels such as the PICA and VBJ by at least 2 mm to avoid cov ering the origin of these important arteries. The involved ASA had to meet the same criteria as the VAs, except if the ASAs were bilateral or with satisfactory collateral circula tion; in those cases, the dissection could be within 2 mm of the ASAs. Although use of covered stent grafts would not sacrifice the parental VAs, we evaluated the compensatory ability of the contralateral VAs in all cases.
Stent Placement Procedures
Before the endovascular procedure, the patient was positioned supine in a dedicated neuroangiography suite and general anesthesia was induced. The patient's heart rate, blood pressure, oxygen saturation, and urine output were monitored throughout the procedure. Two intrave nous paths were established for drug administration. A 6 Fr femoral introducer was placed into the patient's right femoral artery. Systematic heparinization was initiated immediately after the catheter placement, with intermit tent bolus administrations performed throughout the en tire procedure to keep the activated clotting time at 2-2.5 times normal. Selective catheterizations of the VAs were performed using a 6 Fr Envoy guiding catheter (Cordis) for angiography.
Proper covered stent grafts were chosen based on the sizes of the aneurysms and their parent vessel, which was confirmed using angiography. Subsequently, a 6 Fr Envoy guiding catheter was positioned proximally in the affected vessel. A Prowler-14 microcatheter (Cordis) car rying an Essence microguidewire was navigated across the level of the aneurysm with its tip in the distal parent vessel. The Essence microguidewire was then replaced with a Transcend ES 0.014in, 300cm exchange guide wire, so that the Jostent covered stent graft could reach the level of the aneurysm by following the exchange guidewire. After careful angiographic confirmation of the lumen of the aneurysm and the ostium of the ipsilat eral perforating branches (PICA and ASA), stent delivery was accomplished using a single brief dilation of the bal loon up to 8-10 atm. The balloon catheter was withdrawn after deflation, with care taken to maintain the position of the guidewire across the aneurysm. Control angiogra phy was then performed to confirm proper stent position, complete aneurysm obliteration, and avoidance of PICA or ASA occlusion. In cases of incomplete aneurysm oblit eration, postdilation was needed to achieve satisfactory obstruction, and the dilation pressure was increased to a maximum of 16 atm. Following confirmation of aneurysm obliteration us ing control angiography, heparinization was continued for 48 hours and then allowed to taper physiologically. Oral administration of ticlopidine (250 mg twice a day) or clopi dogrel (75 mg daily) was prescribed for 8 weeks, and oral administration of enteric-coated aspirin (100-200 mg dai ly) was continued for 3 months. All patients were evaluated neurologically by experienced neurologists within days af ter discharge, and were then followed up periodically.
Results
Overall Outcomes
Covered stent grafts were successfully placed in 5 patients in this study ( Table 1 ). The size of the aneurysms in the study ranged from 1.5 × 7.5 mm to 4.9 × 13 mm. The diameter of the covered stent grafts that were placed ranged from 3.0 to 4.0 mm, and all had a length of 16 mm. Three patients exhibited transient reflux into the an eurysm sac immediately after the placement of the stent grafts. Balloon reinflation of the stent graft to appose it to the parent vessel wall successfully avoided the reflux in 2 of these 3 patients, and their aneurysms were fully exclud ed from the blood flow. In only 1 case (Case 3), balloon reinflation could not exclude the proximal end of the an eurysm from the circulation. A larger covered stent graft (4.0 × 16 mm) was delivered to the nonexcluded site and was apposed to the vessel wall. Resolution of the reflux in this patient was evident on control angiography per formed later, and the PICAs were carefully preserved.
The stent graft placement failed in 1 patient (Case 6). The patient was admitted because of abrupt change in his level of consciousness and was found to have severe SAH in the posterior cranial fossa. A left intracranial VA dis secting aneurysm was diagnosed in this patient (Hunt and Hess Grade IV) and he underwent interventional covered stent graft treatment. In the intervention procedure, his VA was found to be distorted more than the VAs in previous patients, and severe vasospasm occurred due to repetitive manipulation. Thus, the covered stent graft could not reach the aneurysm, and the treatment was ceased. The patient was returned to the ward for further treatment. Unfortu nately, another severe SAH occurred 3 days later, resulting in the patient's death.
In the 5 patients who received successful stent graft placement, no complications (such as infection, distal em bolization, vessel ruptures, or puncture site complications) occurred in either the immediate postprocedure period or during followup. Postoperative CT demonstrated no signs of hydrocephalus, intracranial hemorrhage, or related brain ischemia.
The 5 remaining patients were followed up for 6-14 months (average 10.4 months). In addition to a neurological examination, 4 patients received control angiography, and 1 patient (Case 5) received 3D CT angiography. No obvi ous intimal hyperplasia occurred. Neither aneurysm refill ing nor severe vessel stenosis was found in any of these 5 patients. Neurological examination results revealed that all patients attained a full recovery without any neurological deficit.
Illustrative Cases
Case 2
This 37yearold male experienced an acuteonset headache while at rest 1 day prior to admission. Subse quently the patient lost consciousness for several minutes, which was followed by vomiting and nuchal rigidity. The patient was treated urgently by the community hospital and then admitted to our unit. The patient had a history of hypertension for 5 years. A neurological examina tion upon admission revealed slight confusion (Hunt and Hess Grade II), dysfunction of the cerebellum, and neck stiffness. The patient's blood pressure was 170/100 mm Hg, and he had a pulse of 94 beats/minute, a respiratory rate of 18 breaths/minute, and a normal temperature. A CT scan revealed moderate SAH in the posterior fossa. Emergency angiography showed a dissecting aneurysm on the VA proximal to the PICA (Fig. 1A and B) . The dis secting aneurysm produced noticeable narrowing of the distal and proximal end of the VA lumen (a "string sign"). The aneurysm was 7.5 mm long, with a 1.5 mm inflow tract and a 1.3 mm outflow tract.
The VA dissecting aneurysm was treated using a 3.0 × 16-mm covered stent graft. Control angiography per formed at the termination of the procedure demonstrated complete occlusion of the inflow and outflow of the an eurysm. No portion of the normalappearing VA or basi lar trunk was covered ( Fig. 1C and D) . The PICAs were patent. The postprocedural course was uneventful. The patient's headache and neck stiffness eventually subsided before he was discharged home 10 days later. After the procedure-and at the 13month followup-the patient had no recurrent hemorrhage and his neurological condi tion was stable. A control angiogram obtained after 13 months revealed a continued exclusion of the aneurysm. The inner wall of the stent graft was smooth, and no obvi ous intimal hyperplasia or stentrelated stenosis was pres ent (Fig. 1E-G) .
Case 5
Ten years prior to this admission this 46yearold wom an suffered a severe headache after drinking alcohol. The next day she suddenly lost consciousness during a medi cal examination at a community hospital and went into a moderate coma for 5 days. Subarachnoid hemorrhage was confirmed by a lumbar puncture, but the patient did not accept any treatment and was automatically discharged. Six months prior to the patient's most recent admission, se vere headache occurred again, but without accompanying coma, vomiting, or paralysis. A CT scan revealed another SAH. A dissecting aneurysm on the right VA was detected by DS angiography. The patient refused medical therapy again and was discharged. Six months later, the asymptom atic patient presented to our unit for further treatment.
The patient had no history of other chronic disease. A neurological examination upon admission found no dis turbance in consciousness (Hunt and Hess Grade 0) and no motor or sensory deficit. The results of DS angiogra phy were identical to the previous results, revealing a VA dissecting aneurysm distal to the PICA. The aneurysm was 5.8 mm long and 5.6 mm wide, with a 4.0 mm inflow tract and a 3.5 mm outflow tract ( Fig. 2A and B) .
Four days after admission, the patient underwent an endovascular intervention. A 4.0 × 16-mm covered stent graft was placed at the site of the dissecting aneurysm, with immediate occlusion of the aneurysm lumen. The balloon was expanded to 10 atm. Control DS angiography con firmed patency of the parental VA, PICA, and AICA ( Fig.  2C and D) . A week later, the patient was in satisfactory condition and was discharged. Her antithrombotic therapy was continued for 3 months. At the 6month followup, a neurological examination showed that the patient had at tained a full recovery without any neurological deficit. No ischemic focus was revealed by the CT scan. Control 3D CT angiography confirmed that the stent graft was in the correct location, that the aneurysm was no longer visible, and that the parental right VA was patent (Fig. 2E) .
Discussion
Intracranial VA dissecting aneurysms are rare but can potentially be deadly, and may serve as a source of thrombus formation or SAH. Spontaneous healing of these aneurysms will occur in some cases, 32,39 thus a con servative strategy is a possible option. To date, most neu rosurgeons treat VA dissecting aneurysms more radically using surgical or endovascular therapies due to the risk of rebleeding and thrombosis.
Current surgical recommendations for the treatment of intracranial VA dissecting aneurysms include clip oc clusion or trapping procedures if the contralateral VA is not particularly smaller in caliber than the ipsilateral VA, or wrapping of the dissecting aneurysm if the parental VA is dominant. Balloon test occlusion is very useful in choosing a surgical strategy. 43 Importantly, if the PICA is involved because of the dissection, then a PICA recon struction procedure-including ophthalmic artery-PICA anastomosis, VA-PICA anastomosis, and others-should be considered to prevent cerebellar infarction and lateral medullary syndrome. 3, 14, 29 Endovascular intervention for intracranial VA dis secting aneurysms can be divided into deconstructive techniques (such as occlusion or sacrifice of the VA) and reconstructive techniques (such as preserving blood flow through the VA). Deconstructive endovascular techniques include proximal occlusion or trapping of the involved VA using coils and/or balloons. 33, 34, 44 Reconstructive endo vascular techniques include porous stent placement alone and porous stentassisted coil embolization, which offers the advantage of parent vessel preservation. 1, 22, 25 Deconstructive surgical and endovascular procedures alone can be sufficient in a variety of cases if they pass balloon test occlusion. After sacrificing the parental VA, the collateral vessels are used exclusively by the patient. But the longevity of a patient's collateral vessels is not predictable during the rest of the patient's life. In theory, reconstructive procedures are more reasonable than de constructive ones, and we believe that the more the parent artery is preserved, if possible, the better the prognosis for the patient. Because the porous stent placement technique cannot promise complete aneurysm obliteration, 7, 25 and the stentassisted coil embolization technique includes the risk of an acute rupture and longterm rebleeding, 24, 40 an innovative covered stent technique was introduced as an alternative reconstruction approach.
Theoretically, a covered stent graft can obliterate the dissecting aneurysm while retaining patency of the par ent vessel. There are several kinds of covered stent grafts used in intracranial aneurysms, including the Symbiot stent (Boston Scientific/Scimed) 2 and Jostent Graftmaster stent.
31
The Symbiot stent is a small, nitinol, self-expandable, flex ible stent that is covered on both the luminal and abluminal sides with a highly porous PTFE. 20 The Jostent stent is a stainless steel stent with the PTFE membrane placed be tween 2 layers of stent struts (a "sandwich" structure). Both of the stents were designed for vascular use in coronary sa phenous vein grafts and are flexible, so they are appropriate for intracranial vascular application. Covered stent grafts have been used primarily in aneurysms involving vascular territories that are easier to access than the intracranial vas culature, such as the abdominal aorta, axillary artery, sub clavian arteries, popliteal artery, iliac and femoral arteries, and even the extracranial carotid artery. 19, 26, 28 Covered stent graft application in intracranial aneu rysms was first reported by Redekop and colleagues in 2001. 35 These authors described 2 AVFs and 2 pseudo aneurysms of the distal extracranial ICA or VA resulting from penetrating trauma, and 2 petrous carotid pseudo aneurysms associated with basal skull fractures, in 6 pa tients. Two of the 6 patients received autologousvein cov ered stent graft placement, and 3 received PTFEcovered stent grafts. To our knowledge, 56 patients with neurovas cular diseases have been treated with covered stent grafts and have been documented since this initial report. Most of the cases were treated using PTFEcovered stent grafts, ranging in size from 3 × 12 mm to 4 × 45 mm. Four of the 50 patients who were followed up achieved nearcomplete occlusion of the CCFs. Complete occlusion of the aneu rysms or CCFs was attained in the other 46 cases (92%). Neurological examination results revealed good or full patient recovery in most of the cases, except for 1 death and several cases of improvement only. Only 2 cases in volving VA dissecting aneurysms were included in these studies (Table 2) .
Because the covered stent occludes any branch of the parent vessel along the length of the stent-which is different than placement of porous stents-avoidance of important branches of the parent vessel should be empha sized during placement of a covered stent. Thus, suitable cases with VA dissecting aneurysms should be chosen carefully due to the extreme importance of these perfora tor branches. In the previous studies, 2 AVFs, 14 CCFs, 5 VA aneurysms (including 2 VA dissecting aneurysms), 6 paraclinoid ICA aneurysms, 6 petrous ICA aneurysms, 19 cavernous ICA aneurysms, 4 petrous and cavernous ICA aneurysms, and 1 middle cerebral artery aneurysm were treated using the covered stent technique ( Table 2) . The petrous or cavernous ICA aneurysms did not involve the crucial perforator artery. The PICAs were carefully excluded in VA aneurysm treatment. 11 In some instances, the ophthalmic artery was sacrificed when treating a par aclinoid ICA aneurysm, without clinical deficit. By view ing multiple angiograms, extreme care has been taken to confirm the positioning of the stent to avoid occlusion of the anterior choroidal artery when treating an intradural ICA aneurysm. 36 In the only case of a middle cerebral artery aneurysm, the lenticulostriate artery was carefully spared during stent placement. 31 The present case series included 6 VA dissecting aneu rysms, in which 4 aneurysms were proximal to the PICAs and 2 were distal to the PICAs. The 6 cases were selected because there was at least 2 mm between the dissecting aneurysm and the PICA. We use this criterion to ensure the important preservation of the PICAs; if they are mistak enly occluded, Wallenberg syndrome may occur or even death. Vertebrobasilar junction occlusion should be care fully avoided as well. If a VA dissecting aneurysm involves the PICA and/or VBJ, vessel anastomosis should first be considered. The ASA should be carefully evaluated before placing a stent, paying particular attention to the pattern of arterial supply and potential collateral circulation.
Reaching the aneurysm neck with the covered stent is another key point of the technique. The restricted flex ibility of the catheter and stent is the main limitation of the operation, which is not a major concern in extracranial stent application due to the uncomplicated nature of this vasculature structure. Thus, cases involving extremely tor tuous or spasmodic proximal arteries should be excluded from the selected cases for this technique. To advance stent grafts into moderately tortuous vessels, 8 Fr guided sys tems or a coaxial (8 Fr within 10 Fr) double-guided sys tem is required. Because the covered stent we used was designed for coronary artery application, it must be noted that inappropriate use of the stent may cause an arterial dissection with subsequent occlusion. In the present series, we presented the case of a patient with SAH (Case 6) with severe vasospasm, causing failure of stent placement. The other 5 patients underwent successful stent placement with a covered stent into the intracranial vasculature lesion of interest.
With continued experience in the use of coronary stents, the induction of intimal hyperplasia has been a sig nificant complication. 16 Unlike in that setting, experimental aneurysm research has demonstrated a slight tendency of intimal proliferation on the vessel wall 1-3 months after the stent graft placement procedure. This slight tendency is believed to be due to a chronic inflammatory reaction against the covered polyurethane membrane. 18 Data from a metaanalysis of 11 randomized studies demonstrated that the pooled rate of restenosis was 25.8% when using stent treatment of coronary artery stenosis. 27 Fortunately, this phenomenon has not been extensively observed in the published series of studies involving intracranial stents, 36 and no severe parent vessel stenosis have been reported. This may be possible because the PTFE layer may not only exclude blood flow through the stent, but also may serve as a physical barrier to prevent late neointimal prolifera tion and stenosis. In addition, the PTFE layer may decrease embolization during stent deployment by trapping debris that otherwise would have been extruded through the stent struts. Furthermore, the PTFE layer may reduce the rate of neointimal hyperplasia and stentrelated stenosis by inhibiting the migration of inflammatory cells and by at tenuating the diffusion of cytokines. 13, 21 In the last 13 inde pendent reports of this technique, 89% of the patients un derwent angiographic followup obtained at 3-48 months postoperatively. Slight asymptomatic intimal hyperplasia occurred in only 3 patients in these studies. No severe inti mal hyperplasia or parent vessel stenosis was reported. In our series, none of the 5 patients who received stent place ments encountered stent-related complications, and no ob vious intimal hyperplasia occurred after the procedure during 6-14 months of followup. Although the prelimi nary result of this moderately long followup study was en couraging, the comprehensive assessment of covered stent grafts will depend on further longterm angiographic and clinical followup data.
To avoid the occurrence of stentrelated thrombosis, a variety of medications have been used. The use of aspirin as well as clopidogrel or ticlopidine is one strategy. Ab ciximab, which binds to the human platelet glycoprotein IIb/IIIa receptor and inhibits platelet aggregation, is an other antiplatelet agent that has been used to avoid throm bosis with this technique. Fibrinolytics such as urokinase have also been attempted and can promote the dissolu tion of thrombi by activating endogenous plasminogen to plasmin. Heparin infusion is maintained throughout the entire stent placement procedure, but after completion of the procedure heparin should be discontinued gradually.
In the present series, we used an aspirin and clopidogrel or ticlopidine strategy to avoid malignant platelet aggre gation, with a satisfactory result.
Conclusions
Covered stent grafts have proven to be effective in treating aneurysms, pseudoaneurysms, direct vessel inju ries, and tumor erosions in aortic, coronary, and periph eral regions. To our knowledge, 13 independent studies involving intracranial applications of covered stent grafts have documented the treatment of fusiform aneurysms, giant aneurysms, traumatic pseudoaneurysms, and CCFs. In this case series, we presented 6 cases involving the ap plication of covered stent grafts for treating VA dissect ing aneurysms. Covered stent grafts were satisfactorily placed on the site of the dissecting aneurysm while care fully preserving the VBJ, PICAs, and ASAs. A moderate ly long followup period showed very positive anatomical outcomes. Although longterm followup and largerscale studies are required for further assessment of validity, the available evidence reveals that covered stent graft posi tioning is an efficient, safe, and microinvasive technique that can be used as a promising tool in treating some VA dissecting aneurysms.
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